Patent · US Active

Use of chymase inhibitors for the treatment of endometriosis, post operative fibrosis and diseases which are characterized by fibrosis formation

US11266646B2 · kind B2 · utility

0Cited by

4References

5Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Michaele PETERS · Berlin, DE
Markus Koch · Berlin, DE
Thomas Zollner · Berlin, DE

Key dates

Filing date	Dec 13, 2017
Grant date	Mar 8, 2022
Priority date	—
Expiry date	Mar 21, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P41/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to the use of bicyclic-substituted uracil derivatives, alone or in combinations with other active ingredients for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of inflammatory and fibrotic disorders, for the treatment of endometriosis, of endometriosis-associated fibrosis, of adenomyosis and of pain associated with an endometriosis disorder and also of postoperative peritoneal fibrosis and adhesion formation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.